Skip to content
Screener

ASP Isotopes, Inc. ASPI Collaboration Revenue — Revenue

Similar metrics at other companies

Cytokinetics logo
CYTKCollaboration Revenues — Revenue
$3.29M+36.2%
Nurix Therapeutics, Inc. logo
NRIXCollaboration revenue — Revenue
$9.04M-35.7%
ePlus logo
PLUSCollaboration — Revenue
$10.18M+24.1%
Cisco Systems, Inc. logo
CSCOCollaboration — Revenue
$1.02B-0.7%
Eli Lilly logo
LLYCollaboration and Other Revenue — Revenue
$1.57B+88.8%
RxSight, Inc. logo
RXSTLicense And Collaboration Revenue — Revenue
$6.5M—

Other financials

Income statement

See full
Revenue$4.2M+279%
Gross profit$1.7M+409%
Operating income-$24.9M-213%
Net income-$7.1M+15.8%
EPS (diluted)-$0.06+50.0%

Balance sheet

See full
Cash & equivalents$211.7M+278%
Total debt$61.9M+1,787%
Total equity$289.0M+580%
Total assets$587.7M+547%

Cash flow

See full
Operating cash flow-$17.8M-460%
CapEx$6.1M+166%
Free cash flow-$23.9M-336%

Valuation

See full
Market cap$557.75M-40.4%
Enterprise value$407.95M-53.7%
P/S20.7×-184×

Profitability

See full
Gross margin17.6%-19.8pp
Operating margin-285.4%-102pp
Net margin-588.6%-112pp
FCF margin-244.6%-92.7pp

Returns & leverage

See full
Return on equity-95.6%-19.3pp
Debt / equity0.2×+0.1×
Current ratio4.4×-2.8×

Where this comes from

Reported directly by ASP Isotopes, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: ASP Isotopes, Inc.’s 10-Q, filed May 20, 2026.

Filed
May 20, 2026, 4:26 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-232658
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue
Product revenue$3,980$1,102
Collaboration revenue200—
Total revenue4,1801,102
Cost of revenue2,514775
Gross profit1,666327
Operating expenses:
Research and development5,2631,530

Item 1. Financial Statements.

FAQ

What is ASP Isotopes, Inc.'s collaboration revenue — revenue?
ASP Isotopes, Inc. (ASPI) reported collaboration revenue — revenue of $200K in Q1 2026.
What does collaboration revenue — revenue mean?
This metric represents the total revenue generated from strategic partnerships, joint development agreements, or collaborative research initiatives focused on isotope enrichment technologies. It captures income derived from shared development efforts rather than direct commercial product sales. Monitoring this stream provides insight into the company's ability to monetize its intellectual property and technical expertise during the pre-commercial development phase.

Ask your AI about ASP Isotopes, Inc.'s collaboration revenue — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude